Cargando…
Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis
Data supporting the use of Tocilizumab (TCZ) in COVID-19 are contrasting and inconclusive. This meta-analysis aimed to assess TCZ effectiveness in reducing the mortality rate in COVID-19 patients. PubMed, Scopus, Embase, Cochrane, WILEY, and ClinicalTrials.gov were searched to evaluate observational...
Autores principales: | Conti, Valeria, Corbi, Graziamaria, Sellitto, Carmine, Sabbatino, Francesco, Maci, Chiara, Bertini, Nicola, De Bellis, Emanuela, Iuliano, Antonio, Davinelli, Sergio, Pagliano, Pasquale, Filippelli, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307114/ https://www.ncbi.nlm.nih.gov/pubmed/34357095 http://dx.doi.org/10.3390/jpm11070628 |
Ejemplares similares
-
Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review
por: Conti, Valeria, et al.
Publicado: (2022) -
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19
por: Sabbatino, Francesco, et al.
Publicado: (2023) -
Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature
por: Conti, Valeria, et al.
Publicado: (2022) -
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation
por: Stefanelli, Berenice, et al.
Publicado: (2022) -
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
por: Conti, Valeria, et al.
Publicado: (2023)